New York A 62: Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology

Status: REFERRED TO INSURANCE (as of 2024-01-03)

State: New York · Session: 2023-2024 · Bill: A 62

Sponsors: Nader Sayegh

View New York A 62 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.